Probiotics for the Prophylaxis of Migraine: A Systematic Review of Randomized Placebo Controlled Trials

Malwina M Naghibi, Richard Day, Samantha Stone, Ashton Harper, Malwina M Naghibi, Richard Day, Samantha Stone, Ashton Harper

Abstract

Migraine is a common and disabling neurological condition with a complex etiology. Recent advances in the understanding of the gut microbiome have shown the role of gut micro-organisms in disease outcomes for distant organs-including the brain. Interventions targeting the gut microbiome have been shown to be effective in multiple neurological diagnoses, but there is little research into the role of the microbiome in migraine. This systematic review seeks to assess the current research landscape of randomized placebo controlled trials utilizing probiotic interventions as migraine prophylaxis. Searches were conducted of scientific databases including PubMed, MEDLINE, and the Cochrane Library, following PRISMA guidelines. Of 68 screened studies, 2 were eligible for analysis. Due to methodological differences, meta-analysis was not possible. Qualitative comparison of the studies demonstrated a dichotomy of results-one trial reported no significant change in migraine frequency and intensity, while the second trial reported highly significant improvements. No clear 'gold standard' currently exists for microbiome research, let alone for migraine-related microbiome research. The heterogeneity of outcome measures used in the two trials included in this systematic review shows the need for a standardization of outcome measures, therefore a series of recommendations for future probiotic-migraine research are included.

Keywords: gut–brain axis; migraine; probiotics; prophylaxis; systematic review.

Conflict of interest statement

All four authors are employees of ADM Protexin.

Figures

Figure 1
Figure 1
PRISMA 2009 flow diagram.

References

    1. Steiner T.J., Stovner L.J., Birbeck G.L. Migraine: The seventh disabler. J. Headache Pain. 2013;14:1. doi: 10.1186/1129-2377-14-1.
    1. Vincent M., Wang S. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1–211.
    1. Buse D.C., Manack A.N., Fanning K.M., Serrano D., Reed M.L., Turkel C.C., Lipton R.B. Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52:1456–1470. doi: 10.1111/j.1526-4610.2012.02223.x.
    1. Lipton R.B. Chronic Migraine, Classification, Differential Diagnosis, and Epidemiology. Headache. 2011;51:77–83. doi: 10.1111/j.1526-4610.2011.01954.x.
    1. Goadsby P.J., Holland P.R., Martins-Oliveira M., Hoffmann J., Schankin C., Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol. Rev. 2017;97:553–622. doi: 10.1152/physrev.00034.2015.
    1. Van Hemert S., Breedveld A.C., Rovers J.M.P., Vermeiden J.P.W., Witteman B.J.M., Smits M.G., de Roos N.M. Migraine Associated with Gastrointestinal Disorders: Review of the Literature and Clinical Implications. Front. Neurol. 2014;5:241. doi: 10.3389/fneur.2014.00241.
    1. Martin C.R., Osadchiy V., Kalani A., Mayer E.A. The Brain-Gut-Microbiome Axis. Cell. Mol. Gastroenterol. Hepatol. 2018;6:133–148. doi: 10.1016/j.jcmgh.2018.04.003.
    1. Cryan J.F., Dinan T.G. Mind-Altering Microorganisms: The Impact of the Gut Microbiota on Brain and Behaviour. Nat. Rev. Neurosci. 2012;13:701–712. doi: 10.1038/nrn3346.
    1. Bercik P., Park A.J., Sinclair D., Khoshdel A., Lu J., Huang X., Deng Y., Blennerhassett P.A., Fahnestock M., Moine D., et al. The Anxiolytic Effect of Bifidobacterium Longum NCC3001 Involves Vagal Pathways for Gut-Brain Communication. Neurogastroenterol. Motil. 2011;23:1132–1139. doi: 10.1111/j.1365-2982.2011.01796.x.
    1. Gasparini C.F., Smith R.A., Griffiths L.R. Genetic and Biochemical Changes of the Serotonergic System in Migraine Pathobiology. J. Headache Pain. 2017;18:2163. doi: 10.1186/s10194-016-0711-0.
    1. Dussor G. Serotonin, 5HT1 Agonists, and Migraine: New Data, but Old Questions Still Not Answered. Curr. Opin. Support. Palliat. Care. 2014;8:137–142. doi: 10.1097/SPC.0000000000000044.
    1. Deen M., Hansen H.D., Hougaard A., Nørgaard M., Eiberg H., Lehel S., Ashina M., Knudsen G.M. High Brain Serotonin Levels in Migraine between Attacks: A 5-HT4 Receptor Binding PET Study. NeuroImage Clin. 2018;18:97–102. doi: 10.1016/j.nicl.2018.01.016.
    1. Mawe G.M., Hoffman J.M. Serotonin Signalling in the Gut-Functions, Dysfunctions and Therapeutic Targets. Nat. Rev. Gastroenterol. Hepatol. 2013;10:564. doi: 10.1038/nrgastro.2013.177.
    1. Martami F., Ghorbani Z., Abolhasani M., Togha M., Meysamie A., Sharifi A., Razeghi Jahromi S. Comorbidity of Gastrointestinal Disorders, Migraine, and Tension-Type Headache: A Cross-Sectional Study in Iran. Neurol. Sci. 2017;39:63–70. doi: 10.1007/s10072-017-3141-0.
    1. Liebregts T., Adam B., Bredack C., Röth A., Heinzel S., Lester S., Downie-Doyle S., Smith E., Drew P., Talley N.J., et al. Immune Activation in Patients With Irritable Bowel Syndrome. Gastroenterology. 2007;132:913–920. doi: 10.1053/j.gastro.2007.01.046.
    1. Bruno P.P., Carpino F., Carpino G., Zicari A. An Overview on Immune System and Migraine. Eur. Rev. Med. Pharmacol. Sci. 2007;11:245.
    1. Kelman L. The Triggers or Precipitants of the Acute Migraine Attack. Cephalalgia. 2007;27:394–402. doi: 10.1111/j.1468-2982.2007.01303.x.
    1. Söderholm J.D., Perdue M.H. Stress and Gastrointestinal Tract. II. Stress and Intestinal Barrier Function. Am. J. Physiol. Liver Physiol. 2001;280:7–13.
    1. Diogenes A., Ferraz C.C.R., Akopian A.N., Henry M.A., Hargreaves K.M. LPS Sensitizes TRPV1 via Activation of TLR4 in Trigeminal Sensory Neurons. J. Dent. Res. 2011;90:759–764. doi: 10.1177/0022034511400225.
    1. Sarkar A., Lehto S.M., Harty S., Dinan T.G., Cryan J.F., Burnet P.W.J. Psychobiotics and the Manipulation of Bacteria–Gut–Brain Signals. Trends Neurosci. 2016;39:763–781. doi: 10.1016/j.tins.2016.09.002.
    1. Kato-Kataoka A., Nishida K., Takada M., Kawai M., Kikuchi-Hayakawa H., Suda K., Ishikawa H., Gondo Y., Shimizu K., Matsuki T., et al. Fermented Milk Containing Lactobacillus Casei Strain Shirota Preserves the Diversity of the Gut Microbiota and Relieves Abdominal Dysfunction in Healthy Medical Students Exposed to Academic Stress. Appl. Environ. Microbiol. 2016;82:3649–3658. doi: 10.1128/AEM.04134-15.
    1. Silberstein S.D., Holland S., Freitag F., Dodick D.W., Argoff C., Ashman E. Evidence-Based Guideline Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1337–1345. doi: 10.1212/WNL.0b013e3182535d20.
    1. Tardiolo G., Bramanti P., Mazzon E. Migraine: Experimental Models and Novel Therapeutic Approaches. Int. J. Mol. Sci. 2019;20:2932. doi: 10.3390/ijms20122932.
    1. Antonaci F., Ghiotto N., Wu S., Pucci E., Costa A. Recent Advances in Migraine Therapy. SpringerPlus. 2016;5:789. doi: 10.1186/s40064-016-2211-8.
    1. Dai Y.-J., Wang H.-Y., Wang X.-J., Kaye A.D., Sun Y.-H. Potential Beneficial Effects of Probiotics on Human Migraine Headache: A Literature Review. Pain Physician. 2017;20:E251–E255.
    1. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J.M., Gavaghan D.J., McQuay H.J. Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary? Control. Clin. Trials. 1996;17:1–12. doi: 10.1016/0197-2456(95)00134-4.
    1. De Roos N.M., Van Hemert S., Rovers J.M.P., Smits M.G., Witteman B.J.M. The Effects of a Multispecies Probiotic on Migraine and Markers of Intestinal Permeability-Results of a Randomized Placebo-Controlled Study. Eur. J. Clin. Nutr. 2017;71:1455–1462. doi: 10.1038/ejcn.2017.57.
    1. Martami F., Togha M., Seifishahpar M., Ghorbani Z., Ansari H., Karimi T., Jahromi S.R. The Effects of a Multispecies Probiotic Supplement on Inflammatory Markers and Episodic and Chronic Migraine Characteristics: A Randomized Double-Blind Controlled Trial. Cephalalgia. 2019;39:841–853. doi: 10.1177/0333102418820102.
    1. Gonzalez A., Hyde E., Sangwan N., Gilbert J.A., Viirre E., Knight R. Migraines Are Correlated with Higher Levels of Nitrate-, Nitrite-, and Nitric Oxide-Reducing Oral Microbes in the American Gut Project Cohort. mSystems. 2016;1:e00105–e00116. doi: 10.1128/mSystems.00105-16.
    1. Artero-Morales M., González-Rodríguez S., Ferrer-Montiel A. TRP Channels as Potential Targets for Sex-Related Differences in Migraine Pain. Front. Mol. Biosci. 2018;5:73. doi: 10.3389/fmolb.2018.00073.
    1. Iyengar S., Johnson K.W., Ossipov M.H., Aurora S.K. CGRP and the Trigeminal System in Migraine. Headache. 2019;59:659–681. doi: 10.1111/head.13529.
    1. Georgescu D., Reisz D., Gurban C.V., Georgescu L.A., Ionita I., Ancusa O.E., Lighezan D. Migraine in Young Females with Irritable Bowel Syndrome: Still a Challenge. Neuropsychiatr. Dis. Treat. 2018;14:21. doi: 10.2147/NDT.S144955.
    1. Linde M., Wm M., Ep C., Dc M., Linde M., Mulleners W.M., Chronicle E.P., Mccrory D.C. Topiramate for the Prophylaxis of Episodic Migraine in Adults ( Review ) Topiramate for the Prophylaxis of Episodic Migraine in Adults. Cochrane Database Syst. Rev. 2014;90:24.
    1. Khera A., McGuire D.K., Murphy S.A., Stanek H.G., Das S.R., Vongpatanasin W., Wians F.H., Grundy S.M., De Lemos J.A. Race and Gender Differences in C-Reactive Protein Levels. J. Am. Coll. Cardiol. 2005;46:464–469. doi: 10.1016/j.jacc.2005.04.051.
    1. Schürks M., Rist P.M., Zee R.Y., Chasman D.I., Kurth T. Tumour Necrosis Factor Gene Polymorphisms and Migraine: A Systematic Review and Meta-Analysis. Cephalalgia. 2011;31:1381–1404. doi: 10.1177/0333102411419022.
    1. Bogaty P., Dagenais G.R., Joseph L., Boyer L., Leblanc A., Bélisle P., Brophy J.M. Time Variability of C-Reactive Protein: Implications for Clinical Risk Stratification. PLoS ONE. 2013;8:e60759. doi: 10.1371/journal.pone.0060759.
    1. Ouwehand A.C. A Review of Dose-Responses of Probiotics in Human Studies. Benef. Microbes. 2017;8:143–151. doi: 10.3920/BM2016.0140.
    1. Douillard F.P., Ribbera A., Kant R., Pietilä T.E., Järvinen H.M., Messing M., Randazzo C.L., Paulin L., Laine P., Ritari J., et al. Comparative Genomic and Functional Analysis of 100 Lactobacillus Rhamnosus Strains and Their Comparison with Strain GG. PLoS Genet. 2013;9:e1003683. doi: 10.1371/journal.pgen.1003683.
    1. Aamodt A.H., Stovner L.J., Hagen K., Zwart J.A. Comorbidity of Headache and Gastrointestinal Complaints. The Head-HUNT Study. Cephalalgia. 2008;28:144–151.
    1. Drummond P.D. Tryptophan Depletion Increases Nausea, Headache and Photophobia in Migraine Sufferers. Cephalalgia. 2006;26:1225–1233. doi: 10.1111/j.1468-2982.2006.01212.x.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel